Axon Enterprise, Inc (NASDAQ:AXON) Shares Bought by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 4.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,625 shares of the biotechnology company's stock after acquiring an additional 410 shares during the period. Whittier Trust Co. of Nevada Inc.'s holdings in Axon Enterprise were worth $5,588,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AXON. Fourth Dimension Wealth LLC purchased a new stake in Axon Enterprise in the fourth quarter valued at $30,000. Bartlett & CO. Wealth Management LLC raised its stake in shares of Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares during the period. Catalyst Capital Advisors LLC purchased a new position in shares of Axon Enterprise during the 1st quarter worth approximately $32,000. Alpine Bank Wealth Management acquired a new stake in Axon Enterprise in the 1st quarter valued at approximately $40,000. Finally, Elequin Capital LP purchased a new stake in Axon Enterprise in the fourth quarter valued at approximately $46,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Analysts Set New Price Targets

AXON has been the subject of a number of research analyst reports. Wolfe Research began coverage on Axon Enterprise in a report on Monday, July 7th. They set an "outperform" rating for the company. Bank of America lifted their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Barclays boosted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Needham & Company LLC lifted their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Finally, JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $734.62.

Insider Activity

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer owned 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CRO Cameron Brooks sold 3,000 shares of Axon Enterprise stock in a transaction on Friday, May 30th. The shares were sold at an average price of $740.76, for a total value of $2,222,280.00. Following the completion of the transaction, the executive owned 19,447 shares in the company, valued at $14,405,559.72. The trade was a 13.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 44,642 shares of company stock valued at $30,500,428 in the last ninety days. 4.40% of the stock is owned by company insiders.

Axon Enterprise Trading Up 0.0%

Shares of AXON stock traded up $0.24 during mid-day trading on Thursday, hitting $743.01. 174,339 shares of the company's stock were exchanged, compared to its average volume of 700,630. The stock has a market cap of $57.84 billion, a price-to-earnings ratio of 179.47, a PEG ratio of 85.86 and a beta of 1.29. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $830.21. The stock has a 50-day simple moving average of $760.96 and a two-hundred day simple moving average of $643.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The firm's quarterly revenue was up 31.3% on a year-over-year basis. During the same period last year, the company earned $1.15 EPS. Equities analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.